Literature DB >> 25124657

New less invasive ventricular reconstruction technique in the treatment of ischemic heart failure.

Rita Faria1, Bruno Melica2, Gustavo Pires-Morais2, Alberto Rodrigues2, José Ribeiro2, Miguel Guerra3, Vasco Gama2, Luís Vouga3.   

Abstract

Ischemic cardiomyopathy is the leading cause of heart failure. In patients with left ventricular (LV) dilatation, low ejection fraction, and transmural scar in an anteroseptal distribution, surgical ventricular reconstruction (SVR) is a treatment option. We describe our first experience with the Less Invasive Ventricular Enhancement (LIVE) technique using the Revivent™ system (Bioventrix Inc., San Ramon, CA), in the treatment of a large anteroapical aneurysm.
Copyright © 2013 Sociedade Portuguesa de Cardiologia. Published by Elsevier España. All rights reserved.

Entities:  

Keywords:  Cardiomiopatia isquémica; Cirurgia sem circulação extracorporal; Heart failure; Insuficiência cardíaca; Ischemic cardiomyopathy; Off-pump surgery; Reconstrução ventricular esquerda; Surgical ventricular reconstruction

Mesh：

Year:  2014        PMID： 25124657     DOI： 10.1016/j.repc.2014.02.015

Source DB:  PubMed          Journal:  Rev Port Cardiol        ISSN： 0870-2551            Impact factor:   1.374


  2 in total

1.  Less invasive ventricular enhancement (LIVE) as potential therapy for ischaemic cardiomyopathy end-stage heart failure.

Authors:  Antonio Loforte; Jacopo Alfonsi; Gregorio Gliozzi; Gianluca Folesani; Mariafrancesca Fiorentino; Mauro Biffi; Giuseppe Marinelli; Roberto Di Bartolomeo; Davide Pacini
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

2.  Catheter ablation of frequent ventricular tachycardia after interventional left ventricular restoration with the Revivent-Transcatheter(™)-system.

Authors:  Christian-Hendrik Heeger; Christian Frerker; Kentaro Hayashi; Tobias Schmidt; Shibu Mathew; Christian Sohns; Lukas Kaiser; Andreas Metzner; Karl-Heinz Kuck; Feifan Ouyang
Journal:  Clin Case Rep       Date:  2016-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.